# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019876
Filing Date
2022-05-12
Accepted
2022-05-12 16:18:40
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | achv-10q_20220331.htm iXBRL | 10-Q | 1857186
2 | EX-31.1 | achv-ex311_7.htm | EX-31.1 | 9064
3 | EX-32.1 | achv-ex321_6.htm | EX-32.1 | 4874
| Complete submission text file | 0001564590-22-019876.txt |  | 6575029

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | achv-20220331.xsd | EX-101.SCH | 50460
5 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | achv-20220331_cal.xml | EX-101.CAL | 37408
6 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | achv-20220331_def.xml | EX-101.DEF | 179475
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | achv-20220331_lab.xml | EX-101.LAB | 371943
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | achv-20220331_pre.xml | EX-101.PRE | 289746
56 | EXTRACTED XBRL INSTANCE DOCUMENT | achv-10q_20220331_htm.xml | XML | 1079021

Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 22918080
SIC: 2835 In Vitro & In Vivo Diagnostic Substances